首页 › 基金 › NEXTBio Capital Management LP › PTGX

NEXTBio Capital Management LP 对 PTGX 的持仓历史

PROTAGONIST THERAPEUTICS INC · 医疗保健

NEXTBio Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 PTGX(PROTAGONIST THERAPEUTICS INC)219,333 股,市值约 US$30.9M,约占其申报组合的 13.45%,在其申报持仓中市值排名第 1 位。 NEXTBio Capital Management LP 最近 4 个申报季度中有 4 个季度披露了 PTGX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)219.33K 股
申报持仓市值$30.90M
组合权重13.45%
首次申报Q4 2025
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

NEXTBio Capital Management LP 对 PTGX 的持仓演变

NEXTBio Capital Management LP 于 Q4 2025 首次披露 PTGX 持仓:229,619 股(约 US$20.1M)。 该持仓在 Q3 2026 达到峰值 219,333 股,市值约 US$30.9M。 在 4 次申报中,NEXTBio Capital Management LP 0 次增持、1 次减持、2 次保持不变。 最近一期申报(Q3 2026)显示持股 219,333 股、市值约 US$30.9M。

逐季持仓明细

季度股数金额变化
Q4 2025 229.62K $20.05M 新进
Q1 2026 229.62K $24.20M 持有
Q2 2026 219.33K $26.89M 减持
Q3 2026 219.33K $30.90M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PTGX 与 13F 数据

PTGX(PROTAGONIST THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 50 只申报持有 PTGX,申报仓位最大的包括:法拉龙资本管理 (US$778.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$778.2M), RTW INVESTMENTS, LP (US$620.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PTGX 的基金

查看 PTGX 的全部基金持有人 →

常见问题

How long has NEXTBio Capital Management LP held PTGX?

NEXTBio Capital Management LP has disclosed PTGX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NEXTBio Capital Management LP's current position in PTGX?

As of Q3 2026, NEXTBio Capital Management LP holds 219.33K shares of PTGX (PROTAGONIST THERAPEUTICS INC), valued at $30.90M, representing 13.45% of its reported portfolio and ranking #1.

Has NEXTBio Capital Management LP been buying or selling PTGX?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP held unchanged its position in PTGX. The position peaked in Q3 2026 at 219.33K shares.

Which other funds hold PTGX?

Other major institutional holders of PTGX include 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., RTW INVESTMENTS, LP, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.